---
document_datetime: 2023-09-21 18:26:28
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/neospect-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: neospect-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.0001278
conversion_datetime: 2025-12-24 06:21:38.330774
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## PROCEDURAL STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION

For procedures finalised after 1 June 2003 please refer to module 8B.

| Scope                                                                                            | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amended on   |
|--------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|-----------------------------------------|
| Minor change in labelling or package leaflet not connected with the SPC (Art. 10.3 Notification) | N/01                 | N                        | 11.04.01                            | 18.05.01                                |
| Change in name and/or address of the marketing authorisation holder                              | I/02                 | I                        | 11.01.02                            | 11.01.02                                |
| Change in the name of a manufacturer of the medicinal product                                    | I/03                 | I                        | 20.05.03                            | 30.06.03                                |

<!-- image -->

Medicinal product no longer authorised Minor change in labelling or package leaflet not connected with the SPC (Art. 10.3 Notification) Change in name and/or address of the marketing authorisation holder Change in the name of a manufacturer of the medicinal product 1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.